PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Quest Diagnostics Incorporated (DGX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS74834L1008
CUSIP74834L100
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$14.26B
EPS$7.49
PE Ratio17.15
PEG Ratio1.52
Revenue (TTM)$9.25B
Gross Profit (TTM)$3.47B
EBITDA (TTM)$1.77B
Year Range$117.60 - $145.40
Target Price$142.29
Short %2.62%
Short Ratio2.81

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Quest Diagnostics Incorporated

Popular comparisons: DGX vs. ^SP500TR, DGX vs. XLF, DGX vs. UNH, DGX vs. SPY, DGX vs. XLU, DGX vs. XLI, DGX vs. ABBV, DGX vs. GILD, DGX vs. MDT, DGX vs. JNJ

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Quest Diagnostics Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
11.84%
19.37%
DGX (Quest Diagnostics Incorporated)
Benchmark (^GSPC)

S&P 500

Returns By Period

Quest Diagnostics Incorporated had a return of 0.24% year-to-date (YTD) and -4.65% in the last 12 months. Over the past 10 years, Quest Diagnostics Incorporated had an annualized return of 11.69%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.


PeriodReturnBenchmark
Year-To-Date0.24%6.30%
1 month6.33%-3.13%
6 months11.84%19.37%
1 year-4.65%22.56%
5 years (annualized)10.06%11.65%
10 years (annualized)11.69%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-6.36%-2.76%6.58%
2023-7.33%7.38%5.48%0.47%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of DGX is 38, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of DGX is 3838
Quest Diagnostics Incorporated(DGX)
The Sharpe Ratio Rank of DGX is 4040Sharpe Ratio Rank
The Sortino Ratio Rank of DGX is 3333Sortino Ratio Rank
The Omega Ratio Rank of DGX is 3333Omega Ratio Rank
The Calmar Ratio Rank of DGX is 4242Calmar Ratio Rank
The Martin Ratio Rank of DGX is 4343Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


DGX
Sharpe ratio
The chart of Sharpe ratio for DGX, currently valued at -0.20, compared to the broader market-2.00-1.000.001.002.003.00-0.20
Sortino ratio
The chart of Sortino ratio for DGX, currently valued at -0.15, compared to the broader market-4.00-2.000.002.004.006.00-0.15
Omega ratio
The chart of Omega ratio for DGX, currently valued at 0.98, compared to the broader market0.501.001.500.98
Calmar ratio
The chart of Calmar ratio for DGX, currently valued at -0.14, compared to the broader market0.001.002.003.004.005.00-0.14
Martin ratio
The chart of Martin ratio for DGX, currently valued at -0.38, compared to the broader market0.0010.0020.0030.00-0.38
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-2.00-1.000.001.002.003.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.006.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.001.002.003.004.005.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.007.64

Sharpe Ratio

The current Quest Diagnostics Incorporated Sharpe ratio is -0.20. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.20
1.92
DGX (Quest Diagnostics Incorporated)
Benchmark (^GSPC)

Dividends

Dividend History

Quest Diagnostics Incorporated granted a 2.11% dividend yield in the last twelve months. The annual payout for that period amounted to $2.88 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend$2.88$2.79$3.26$2.42$2.21$2.12$1.95$1.80$1.58$1.47$1.29$1.20

Dividend yield

2.11%2.02%2.08%1.40%1.85%1.99%2.34%1.83%1.72%2.07%1.92%2.24%

Monthly Dividends

The table displays the monthly dividend distributions for Quest Diagnostics Incorporated. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.71$0.00$0.00
2023$0.66$0.00$0.00$0.71$0.00$0.00$0.71$0.00$0.00$0.71$0.00$0.00
2022$0.62$0.00$0.00$0.66$0.00$0.66$0.66$0.00$0.00$0.66$0.00$0.00
2021$0.56$0.00$0.00$0.62$0.00$0.00$0.62$0.00$0.00$0.62$0.00$0.00
2020$0.53$0.00$0.00$0.56$0.00$0.00$0.56$0.00$0.00$0.56$0.00$0.00
2019$0.53$0.00$0.00$0.53$0.00$0.00$0.53$0.00$0.00$0.53$0.00$0.00
2018$0.45$0.00$0.00$0.50$0.00$0.00$0.50$0.00$0.00$0.50$0.00$0.00
2017$0.45$0.00$0.00$0.45$0.00$0.00$0.45$0.00$0.00$0.45$0.00$0.00
2016$0.38$0.00$0.00$0.40$0.00$0.00$0.40$0.00$0.40$0.00$0.00$0.00
2015$0.33$0.00$0.00$0.38$0.00$0.00$0.38$0.00$0.00$0.38$0.00$0.00
2014$0.30$0.00$0.00$0.33$0.00$0.00$0.33$0.00$0.00$0.33$0.00$0.00
2013$0.30$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%2.1%
Quest Diagnostics Incorporated has a dividend yield of 2.11%, which is quite average when compared to the overall market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%33.1%
Quest Diagnostics Incorporated has a payout ratio of 33.07%, which is quite average when compared to the overall market. This suggests that Quest Diagnostics Incorporated strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-16.47%
-3.50%
DGX (Quest Diagnostics Incorporated)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Quest Diagnostics Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Quest Diagnostics Incorporated was 49.46%, occurring on Feb 14, 2003. Recovery took 452 trading sessions.

The current Quest Diagnostics Incorporated drawdown is 16.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.46%May 6, 2002198Feb 14, 2003452Dec 1, 2004650
-44.75%Dec 29, 200057Mar 22, 200163Jun 21, 2001120
-36.6%Mar 6, 202021Apr 3, 202015Apr 27, 202036
-36.26%Sep 1, 2006536Oct 17, 2008870Apr 2, 20121406
-36.24%Jun 10, 199885Oct 8, 1998127Apr 13, 1999212

Volatility

Volatility Chart

The current Quest Diagnostics Incorporated volatility is 7.17%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%NovemberDecember2024FebruaryMarchApril
7.17%
3.58%
DGX (Quest Diagnostics Incorporated)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Quest Diagnostics Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items